{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:05:38Z","timestamp":1790813138605,"version":"4.1.0"},"reference-count":181,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL149727"],"award-info":[{"award-number":["R01 HL149727"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) represents a major public health crisis that has caused the death of nearly six million people worldwide. Emerging data have identified a deficiency of circulating arginine in patients with COVID-19. Arginine is a semi-essential amino acid that serves as key regulator of immune and vascular cell function. Arginine is metabolized by nitric oxide (NO) synthase to NO which plays a pivotal role in host defense and vascular health, whereas the catabolism of arginine by arginase to ornithine contributes to immune suppression and vascular disease. Notably, arginase activity is upregulated in COVID-19 patients in a disease-dependent fashion, favoring the production of ornithine and its metabolites from arginine over the synthesis of NO. This rewiring of arginine metabolism in COVID-19 promotes immune and endothelial cell dysfunction, vascular smooth muscle cell proliferation and migration, inflammation, vasoconstriction, thrombosis, and arterial thickening, fibrosis, and stiffening, which can lead to vascular occlusion, muti-organ failure, and death. Strategies that restore the plasma concentration of arginine, inhibit arginase activity, and\/or enhance the bioavailability and potency of NO represent promising therapeutic approaches that may preserve immune function and prevent the development of severe vascular disease in patients with COVID-19.<\/jats:p>","DOI":"10.3390\/metabo12030240","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T22:29:43Z","timestamp":1647210583000},"page":"240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6715-4352","authenticated-orcid":false,"given":"William","family":"Durante","sequence":"first","affiliation":[{"name":"Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2020, February 21). WHO Coronavirus Disease (COVID) Dashboard. Available online: http:\/\/covid19.who.int."},{"key":"ref_2","first-page":"e2020036","article-title":"Possible modes of transmission of novel coronavirus SARS-COVID-2: A review","volume":"91","author":"Mukra","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe COVID-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/1744666X.2021.1847640","article-title":"Natural history of COVID-19 and therapeutic options","volume":"16","author":"Gautret","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00636-17","DOI":"10.1128\/IAI.00636-17","article-title":"What is a host? Attributes of individual susceptibility","volume":"86","author":"Casadevall","year":"2018","journal-title":"Infect Immun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fimmu.2017.00093","article-title":"Arginine metabolism in myeloid cells shapes innate and adaptive immunity","volume":"8","author":"Rodriguez","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"695238","DOI":"10.3389\/fimmu.2021.695238","article-title":"Amino acid transport and metabolism in myeloid function","volume":"12","author":"Halaby","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2013.00149","article-title":"Arginase: The emerging therapeutic target for vascular oxidative stress and inflammation","volume":"4","author":"Yang","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","article-title":"Arginase: An emerging key player in the mammalian immune system","volume":"158","author":"Munder","year":"2009","journal-title":"Br. J. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1007\/s00018-021-03828-4","article-title":"Arginine-dependent immune responses","volume":"78","author":"Reith","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: Nitric oxide and beyond","volume":"336","author":"Wu","year":"1988","journal-title":"Biochem. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/CBB:35:1:19","article-title":"Regulation of L-arginine transport and metabolism in vascular smooth muscle cells","volume":"35","author":"Durante","year":"2001","journal-title":"Cell Biochem. Biophys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1440-1681.2007.04638.x","article-title":"Arginase: A critical regulator of nitric oxide synthesis and vascular function","volume":"34","author":"Durante","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fimmu.2013.00111","article-title":"Role of arginase in vessel wall remodeling","volume":"4","author":"Durante","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11906-006-0041-8","article-title":"Endothelial arginase: A new target in atherosclerosis","volume":"8","author":"Yang","year":"2006","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cvr\/cvt036","article-title":"Arginase as a potential target in the treatment of cardiovascular disease: Reversal of arginine steal?","volume":"98","author":"Pernow","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1152\/physrev.00037.2016","article-title":"Arginase: A multifaceted enzyme important in health and disease","volume":"98","author":"Caldwell","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e144734","DOI":"10.1172\/JCI144734","article-title":"Functional monocytic myeloid-derived suppressor cells increase blood but not airways and predict COVID-19 severity","volume":"131","author":"Vangeti","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1432-1033.2003.03559.x","article-title":"Argininosuccinate synthetase for the urea cycle to the citrulline-NO cycle","volume":"270","author":"Husson","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: Regulation and function","volume":"33","author":"Fostermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0305-0491(95)02138-8","article-title":"Comparative properties of arginase","volume":"114B","author":"Jenkinson","year":"1996","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.bi.53.070184.003533","article-title":"Polyamines","volume":"53","author":"Tabor","year":"1984","journal-title":"Ann. Rev. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.RES.83.2.217","article-title":"Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase activity","volume":"83","author":"Durante","year":"1998","journal-title":"Circ. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.99-0960com","article-title":"Physiologic cyclic stretch directs L-arginine transport and metabolism to collagen synthesis in vascular smooth muscle cells","volume":"14","author":"Durante","year":"2000","journal-title":"FASEB J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.103.8.1121","article-title":"Transforming growth factor-\u03b21 stimulates L-arginine transport and metabolism in vascular smooth muscle cells: Role in polyamine and collagen synthesis","volume":"103","author":"Durante","year":"2001","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1152\/japplphysiol.91393.2008","article-title":"Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats","volume":"107","author":"Kim","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/pupt.2001.0297","article-title":"Concomitant down-regulation of L-arginine transport and nitric oxide (NO) synthesis in rat alveolar macrophages by the polyamine spermine","volume":"14","author":"Mossner","year":"2001","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1073\/pnas.0735876100","article-title":"Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox","volume":"100","author":"Lee","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/bbrc.1994.1909","article-title":"Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-L-arginine: Implications for the regulation of nitric oxide biosynthesis by arginase","volume":"202","author":"Daghigh","year":"1994","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.107.157727","article-title":"Inducible NO synthase-dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction","volume":"101","author":"Santhanam","year":"2007","journal-title":"Circ. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1084\/jem.181.6.2171","article-title":"Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle intermediates","volume":"181","author":"Karupiah","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000150434","article-title":"Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV","volume":"38","author":"Kawanishi","year":"1995","journal-title":"Intervirology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/jvi.69.2.910-915.1995","article-title":"Gamma interferon-induced nitric oxide-mediated inhibition of vaccinia virus replication","volume":"69","author":"Harris","year":"1995","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1172\/JCI118613","article-title":"Nitric oxide inhibits viral replication in murine myocarditis","volume":"97","author":"Lowenstein","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80003-5","article-title":"An antiviral mechanism of nitric oxide: Inhibition of a viral protease","volume":"10","author":"Saura","year":"1999","journal-title":"Immunity"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/JVI.79.3.1966-1969.2005","article-title":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus","volume":"79","author":"Akerstrom","year":"2005","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.09.007","article-title":"Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected","volume":"395","author":"Akerstrom","year":"2009","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_41","first-page":"R237","article-title":"Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages","volume":"276","author":"Louis","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_42","first-page":"E459","article-title":"Arginine metabolism in wounds","volume":"254","author":"Albina","year":"1988","journal-title":"Am. J. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4049\/jimmunol.1301913","article-title":"Repression of arginase-2 expression in dendritic cells by microRNA-155 is critical for promoting T cell proliferation","volume":"193","author":"Irla","year":"2014","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2006-11-010389","article-title":"Suppression of T cell functions by granulocyte arginase","volume":"108","author":"Munder","year":"2006","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1189\/jlb.1109737","article-title":"Exocytosis of azurophil and arginase-1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation","volume":"89","author":"Rotondo","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell receptor responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-Arginine modulates CD3zeta expression and T cell function in activated T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"l-Arginine-depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res."},{"key":"ref_50","first-page":"958s","article-title":"L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells","volume":"7","author":"Taheri","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.4049\/jimmunol.1001224","article-title":"L-Arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression","volume":"185","author":"Rodriguez","year":"2010","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-Arginine availability regulates T-lymphocyte cell cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"25815","DOI":"10.1074\/jbc.C116.763623","article-title":"Proliferating helper T cells require Rictor\/mTORC2 complex to integrate signals from limiting environmental amino acids","volume":"291","author":"Murray","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.168.2.689","article-title":"Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism","volume":"168","author":"Mazzoni","year":"2002","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.4049\/jimmunol.167.10.5583","article-title":"Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide","volume":"167","author":"Saio","year":"2001","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.imbio.2007.09.008","article-title":"Role of arginine metabolism in immunity and immunopathology","volume":"212","author":"Peranzoni","year":"2007","journal-title":"Immunobiol"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1172\/JCI20225","article-title":"Inducible nitric oxide synthase in T cells regulates T cell death and immune memory","volume":"113","author":"Vig","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI0216143","article-title":"Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice","volume":"110","author":"Kwikkers","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ni.2806","article-title":"Inducible nitric oxide synthase is a major intermediate in signaling pathways for the survival of plasma cells","volume":"15","author":"Saini","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(91)92456-C","article-title":"Stimulation of lymphocyte natural cytotoxicity by L-arginine","volume":"337","author":"Park","year":"1991","journal-title":"Lancet"},{"key":"ref_61","first-page":"205","article-title":"L-arginine stimulates host defenses in patients with breast cancer","volume":"115","author":"Brittenden","year":"1994","journal-title":"Surgery"},{"key":"ref_62","first-page":"142","article-title":"Immunomodulatory mechanisms of arginine","volume":"104","author":"Reynolds","year":"1988","journal-title":"Surgery"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cellimm.2012.11.018","article-title":"Altered functions of natural killer cells in response to L-arginine availability","volume":"280","author":"Lamas","year":"2012","journal-title":"Cell. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.163.3.1473","article-title":"Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cells death by regulating expression of TNF-alpha","volume":"163","author":"Faruke","year":"1999","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1365-3083.2000.00762.x","article-title":"Interleukin-2-induced nitric oxide synthase and nuclear factor-kappaB activity in activated natural killer cells and the production of interferon-gamma","volume":"52","author":"Jyothi","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.4049\/jimmunol.0803523","article-title":"Regulation of NK cell function by human granulocyte arginase","volume":"182","author":"Oberlies","year":"2009","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.4049\/jimmunol.1501881","article-title":"Hepatitits C virus-induced myeloid-derived suppressor cells suppress NK cell IFN-\u03b3 production by altering cellular metabolism via arginase-1","volume":"196","author":"Goh","year":"2016","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/ehjci\/jet256","article-title":"Non-invasive endothelial function testing and the risk of adverse outcomes: A systematic review and meta-analysis","volume":"15","author":"Xu","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd4623","article-title":"Strategies to increase nitric oxide signalling in cardiovascular disease","volume":"14","author":"Lundberg","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"H651","DOI":"10.1152\/ajpheart.00755.2012","article-title":"Insights into the arginine paradox: Evidence against the importance of subcellular localization of arginase and eNOS","volume":"305","author":"Elms","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijcard.2019.11.004","article-title":"Improvement in endothelial function in cardiovascular disease\u2014is arginase the target?","volume":"301","author":"Mahdi","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"C952","DOI":"10.1152\/ajpcell.00466.2009","article-title":"Thrombin induces endothelial arginase through AP-1 activation","volume":"298","author":"Zhu","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jvs.2008.02.030","article-title":"Arginase blockade lessens endothelial dysfunction after thrombosis","volume":"48","author":"Lewis","year":"2008","journal-title":"Vasc. Surg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.107.169573","article-title":"Endothelial arginase II: A novel target for the treatment of atherosclerosis","volume":"102","author":"Ryoo","year":"2008","journal-title":"Circ. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/oby.20969","article-title":"Arginase promotes endothelial dysfunction and hypertension in obese rats","volume":"23","author":"Johnson","year":"2015","journal-title":"Obesity"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2013.00119","article-title":"Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats","volume":"4","author":"Johnson","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/CIRCRESAHA.107.155028","article-title":"Diabetes-induced coronary vascular dysfunction involves increased arginase activity","volume":"102","author":"Romero","year":"2008","journal-title":"Circ. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"R1057","DOI":"10.1152\/ajpregu.00758.2004","article-title":"Arginase inhibition restores arterial endothelial dysfunction in Dahl rats with salt-induced hypertension","volume":"288","author":"Johnson","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_79","first-page":"384","article-title":"Vascular arginase contributes to arteriolar endothelial dysfunction in a rat model of hemorrhagic shock","volume":"69","author":"Johnson","year":"2010","journal-title":"J. Trauma."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cvr\/cvp303","article-title":"Arginase inhibition mediates cardioprotection during ischemia-reperfusion","volume":"85","author":"Jung","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1213\/ANE.0000000000001378","article-title":"Arginase inhibition reverses endothelial dysfunction, pulmonary hypertension, and vascular stiffness in transgenic sickle cell mice","volume":"123","author":"Steppan","year":"2016","journal-title":"Anesth. Analg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/01.hjh.0000166837.78559.93","article-title":"Arginase inhibition reduced endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats","volume":"23","author":"Demougeot","year":"2005","journal-title":"J. Hypertens."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"L112","DOI":"10.1152\/ajplung.00101.2012","article-title":"IL-13 receptor \u03b12-arginase 2 pathway mediates IL-13-iinduced pulmonary hypertension","volume":"304","author":"Cho","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"9260","DOI":"10.1073\/pnas.161294898","article-title":"Elevated arginase 1 expression in rat aortic smooth muscle cells increases cell proliferation","volume":"98","author":"Wei","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/ATVBAHA.108.183392","article-title":"Arginase promotes neointima formation in rat injured carotid arteries","volume":"29","author":"Peyton","year":"2009","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cvr\/cvq081","article-title":"Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension","volume":"87","author":"Bagnost","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Bhatta, Y., Yao, L., Haque, H.A., Shatanawi, A., Xu, Z., Caldwell, R.B., and Caldwell, R.W. (2015). Angiotensin II-induced arterial thickening, fibrosis and stiffening involve elevated arginase function. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127110"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"L503","DOI":"10.1152\/ajplung.00328.2014","article-title":"Arginase inhibition prevents bleomycin-induced pulmonary vascular remodeling, and collagen deposition in neonatal rat lungs","volume":"308","author":"Grasemann","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1073\/pnas.1602978113","article-title":"HIF2\u03b1-arginase axis is essential for the development of pulmonary hypertension","volume":"113","author":"Cowburn","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/cvr\/cvx164","article-title":"Obesity-induced vascular dysfunction and arterial stiffening requires endothelial arginase 1","volume":"113","author":"Bhatta","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jth.14848","article-title":"Thrombocytopenia and its association with mortality in patients with COVID-19","volume":"18","author":"Yang","year":"2020","journal-title":"J. Thromb. Haemostas"},{"key":"ref_96","first-page":"876","article-title":"D-dimer is associated with severity of coronavirus disease 2019: A pooled analysis","volume":"18","author":"Lippi","year":"2020","journal-title":"J. Thromb. Haemostas."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Acta"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/CIRCULATIONAHA.120.050809","article-title":"Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction","volume":"142","author":"Modin","year":"2020","journal-title":"Circulation"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of COVID-19 in the young","volume":"382","author":"Oxley","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Gonzalez-Urquijo, M., Gonzalez-Rayes, J.M., Castro-Varela, A., Hinojosa-Gonzalez, D.E., Ramos-Cazares, R.E., Vazquez-Garza, E., Paredes-Vazquez, J.G., Castillo-Perez, M., Jerjes-Sanchez, C., and Fabiani, M.A. (2021). Unexpected arterial thrombosis and acute limb ischemia in COVID-19 patients. Results from the Ibero-Latin American acute arterial thrombosis registry in COVID-19: (ARTICO-19). Vascular, 1\u20138.","DOI":"10.1177\/17085381211052033"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis, in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","article-title":"Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: A case series","volume":"396","author":"Bradley","year":"2020","journal-title":"Lancet"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: Different respiratory treatments for different phenotypes?","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series","volume":"24","author":"Rapkiewicz","year":"2020","journal-title":"EClinical"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.33963\/KP.a2021.0154","article-title":"COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications","volume":"79","author":"Viola","year":"2021","journal-title":"Kardiol. Pol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","article-title":"Thrombocytopathy and endothelialiopathy: Crucial contributors to COVID-19 thromboinflammation","volume":"18","author":"Gu","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ajpath.2021.05.007","article-title":"COVID-19 Vasculopathy: Mounting evidence for an indirect mechanism of endothelial injury","volume":"191","author":"Nicosia","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2021.11.010","article-title":"Endothelial contribution to COVID-19: An update on mechanisms and therapeutic implications","volume":"164","author":"Ma","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.mayocp.2021.06.027","article-title":"Viral endothelial dysfunction: A unifying mechanism for COVID-19","volume":"96","author":"Prasad","year":"2021","journal-title":"Mayo. Clin. Proc."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endothelialitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.7326\/L20-0882","article-title":"Cardiac endothelialitis and multisystem inflammatory syndrome after COVID-19","volume":"173","author":"Fox","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jmv.26119","article-title":"Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CIVD-19 patients with diarrhea","volume":"93","author":"Carnevale","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1111\/jdv.16760","article-title":"An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient","volume":"34","author":"Negrini","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"190","author":"Escher","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"597926","DOI":"10.3389\/fped.2021.597926","article-title":"Case report: Inflammation and endothelial injury profiling of COVID-19 pediatric multisystem inflammatory syndrome (MIS-C)","volume":"9","author":"Fraser","year":"2021","journal-title":"Fronti. Pediatr."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"100781","DOI":"10.1016\/j.nmni.2020.100781","article-title":"Stroke in young adult with mild COVID-19 suggesting endothelialitis","volume":"38","author":"Crippa","year":"2020","journal-title":"New Microbes New Infect."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/infdis\/jiaa528","article-title":"Circulating endothelial cells as a marker of endothelial injury in severe COVID-19","volume":"222","author":"Guervilly","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"L1237","DOI":"10.1152\/ajplung.00202.2020","article-title":"P-selectin blockade in COVID-19-related ARDS","volume":"318","author":"Neri","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10456-020-09730-0","article-title":"Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients","volume":"23","author":"Smadja","year":"2020","journal-title":"Angiogenesis"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-021-03499-4","article-title":"Markers of endothelial and epithelial pulmonary injury in mechanically-ventilated COVID-19 ICU patients","volume":"25","author":"Spadaro","year":"2021","journal-title":"Crit. Care"},{"key":"ref_121","first-page":"386","article-title":"Systemic microvascular dysfunction in COVID-19","volume":"10","author":"Sabioni","year":"2020","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"104119","DOI":"10.1016\/j.mvr.2020.104119","article-title":"Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser doppler perfusion monitoring and cytokine\/chemokine analysis","volume":"134","author":"Sabioni","year":"2021","journal-title":"Microvasc. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00897.2020","article-title":"Vascular alterations among young adults with SARS-CoV-2","volume":"320","author":"Ratchford","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_124","first-page":"421","article-title":"Endothelial cell dysfunction and the glycocalyx\u2014a vicious circle","volume":"71\u201372","author":"Zhang","year":"2019","journal-title":"Matrix Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e0194","DOI":"10.1097\/CCE.0000000000000194","article-title":"Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: Implications for microvascular platelet aggregation","volume":"2","author":"Fraser","year":"2020","journal-title":"Crit. Care Explor."},{"key":"ref_126","first-page":"e22052","article-title":"Pathogenesis of COVID-19 described through the lens of undersulfated and degraded epithelial and endothelial glycocalyx","volume":"36","author":"Aldous","year":"2022","journal-title":"FASEB J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"605908","DOI":"10.3389\/fphys.2020.605908","article-title":"SARS-CoV-2 mediated endothelial dysfunction. The potential role of chronic oxidative stress","volume":"11","author":"Chang","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Adebayo, A., Varzideh, F., Wilson, S., Gambardella, J., Eacobacci, M., Jankauskas, S.S., Donkor, K., Kansakar, U., Trimarco, V., and Mone, P. (2021). L-Arginine and COVID-19: An update. Nutrients, 13.","DOI":"10.3390\/nu13113951"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.niox.2021.04.003","article-title":"Implications of SARS-CoV-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems","volume":"111\u2013112","author":"Guimaraes","year":"2021","journal-title":"Nitric. Oxide."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2020.12.008","article-title":"The role of NO in COVID-19 and potential therapeutic strategies","volume":"163","author":"Fang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"173494","DOI":"10.1016\/j.ejphar.2020.173494","article-title":"Application of methylene blue-vitamin C-N-acetyl cysteine for treatment of critical ill COVID-19 patients, report of a phase -I clinical trial","volume":"885","author":"Alamdari","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Derakhshani, A., Hemmat, N., Asadzadeh, Z., Ghaseminia, M., Shadbad, M.A., Jadideslam, G., Silvestris, N., Racanelli, V., and Baradaran, B. (2021). Arginase 1 (Arg1) as an up-regulated gene in COVID-19 patients: A promising marker of COVID-19 immunopathy. J. Clin. Med., 10.","DOI":"10.3390\/jcm10051051"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fgene.2020.00641","article-title":"Neutrophils, crucial, or harmful immune cells involved in coronavirus infection: A bioinformatics study","volume":"11","author":"Hemmat","year":"2020","journal-title":"Front. Genet."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"103215","DOI":"10.1016\/j.isci.2021.103215","article-title":"The immune landscape of SARS-CoV-2-associated multisystem inflammatory syndrome in children (MIS-C) from acute disease to recovery","volume":"24","author":"Syrimi","year":"2021","journal-title":"iScience"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10875-020-00920-5","article-title":"SARS-CoV-2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage","volume":"41","author":"Reizine","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"695972","DOI":"10.3389\/fimmu.2021.695972","article-title":"Severe COVID-19 is characterized by an impaired type I interferon response and elevated levels of arginase producing granulocytic myeloid derived suppressor cells","volume":"12","author":"Dean","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Sacchi, A., Grassi, G., Notari, S., Gili, S., Bordoni, V., Tartaglia, E., Casetti, R., Cimini, E., Mariotti, D., and Garotto, G. (2021). Expansion of myeloid derived suppressor cells contributes to platelet activation by L-arginine deprivation during SARS-CoV-2 infection. Cells, 10.","DOI":"10.3390\/cells10082111"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"D\u2019Alessandro, A., Thomas, T., Akpan, I.J., Reisz, J.A., Cendali, F.I., Gamboni, F., Nemkov, T., Thangaraju, K., Katneni, U., and Tanaka, K. (2021). Biological and clinical factors contributing to the metabolic heterogeneity of hospitalized patients with and without COVID-19. Cells, 10.","DOI":"10.21203\/rs.3.rs-480167\/v1"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"She","year":"2020","journal-title":"Cell"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1038\/s41467-021-24482-1","article-title":"The trans-omics landscape of COVID-19","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e2101708118","DOI":"10.1073\/pnas.2101708118","article-title":"Altered amino acid profile in patients with SARS-CoV-2 infection","volume":"118","author":"Rees","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk","volume":"53","author":"Tang","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_143","first-page":"202","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"Canzano","year":"2021","journal-title":"J. Am. Coll. Cardiol. Basic Trans Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/jn\/130.11.2626","article-title":"Arginine nutrition and cardiovascular function","volume":"130","author":"Wu","year":"2000","journal-title":"J. Nutr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-030-45328-2_3","article-title":"Amino acid in circulatory function and health","volume":"1265","author":"Durante","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ijid.2020.10.100","article-title":"Arginine depletion as a therapeutic approach for patients with COVID-19","volume":"102","author":"Grimes","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Melano, I., Kuo, L.-L., Lo, Y.-C., Sung, P.-W., Tien, N., and Su, W.-C. (2021). Effects of basic amino acids and their derivatives on SARS-CoV-2 and influenza-A virus infection. Viruses, 13.","DOI":"10.3390\/v13071301"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"101125","DOI":"10.1016\/j.eclinm.2021.101125","article-title":"Effects of adding L-arginine to standard therapy with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis","volume":"40","author":"Fiorentino","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00726-018-2594-7","article-title":"Safety of dietary supplementation with arginine in adult humans","volume":"50","author":"McNeal","year":"2018","journal-title":"Amino Acids"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.2007.02990.x","article-title":"Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: Impact on nitric oxide metabolism","volume":"65","author":"Schwedhelm","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12948-020-00139-0","article-title":"Vitamin D and COVID-19: An update on evidence and potential therapeutic implications","volume":"18","author":"Murdaca","year":"2020","journal-title":"Clin. Mol. Allergy"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"102350","DOI":"10.1016\/j.autrev.2019.102350","article-title":"Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications","volume":"18","author":"Murdaca","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"339","DOI":"10.31083\/j.rcm.2020.03.131","article-title":"Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19","volume":"21","author":"Zhang","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/01.CIR.101.18.2160","article-title":"Oral L-arginine in patients with coronary artery disease on medical management","volume":"101","author":"Blum","year":"2000","journal-title":"Circulation"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIRCULATIONAHA.106.683656","article-title":"L-arginine supplementation in peripheral artery disease: No benefit and possible harm","volume":"116","author":"Wilson","year":"2003","journal-title":"Circulation"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbrc.2009.06.091","article-title":"Paradoxical effect of L-arginine: Acceleration of endothelial cell senescence","volume":"386","author":"Scalera","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/joim.12461","article-title":"Arginase inhibition improves endothelial function with familial hypercholesterolemia irrespective of their cholesterol level","volume":"279","author":"Kovamees","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1210\/jc.2016-2007","article-title":"Arginase inhibition improves microvascular endothelial function in patients with type 2 diabetes mellitus","volume":"101","author":"Kovamees","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/rej.2018.2135","article-title":"Arginase inhibition improves endothelial function in age-dependent manner in healthy elderly humans","volume":"22","author":"Madhi","year":"2019","journal-title":"Rejuvenation Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/jphysiol.2007.128959","article-title":"Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilation in hypertensive humans","volume":"581","author":"Holowatz","year":"2007","journal-title":"J. Physiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"G512","DOI":"10.1152\/ajpgi.00227.2006","article-title":"Liver I\/R injury is improved by the arginase inhibitor N(omega)-hydroxy-nor-L-arginine (nor-NOHA)","volume":"292","author":"Reid","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1476-5381.2008.00036.x","article-title":"The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries","volume":"156","author":"Huynh","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"115658","DOI":"10.1016\/j.bmc.2020.115658","article-title":"Boronic acid-based arginase inhibitors in cancer immunotherapy","volume":"28","author":"Borek","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: Deleterious impact on infected patients","volume":"13","author":"Ejaz","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/AOG.0000000000004128","article-title":"High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19)","volume":"136","author":"Wiegand","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e0277","DOI":"10.1097\/CCE.0000000000000277","article-title":"Rescue treatment with high-dose gaseous nitric oxide in spontaneously breathing patients with severe coronavirus disease 2019","volume":"2","author":"Weigand","year":"2020","journal-title":"Crit. Care Explor."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2021.08.003","article-title":"Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia","volume":"116","author":"Gianni","year":"2021","journal-title":"Nitric Oxide"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1164\/rccm.202004-0937LE","article-title":"Outpatient inhaled nitric oxide in a patient with vasoreactive idiopathic pulmonary arterial hypertension and COVID-19 infection","volume":"202","author":"Zamanian","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s13054-020-03371-x","article-title":"Inhaled nitric oxide for critically ill COVID-19 patients: A prospective study","volume":"24","author":"Huette","year":"2020","journal-title":"Crit. Care"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e0471","DOI":"10.1097\/CCE.0000000000000471","article-title":"Respiratory physiology of prone positioning with and without inhaled nitric oxide across the coronavirus disease 2019 acute respiratory distress syndrome severity spectrum","volume":"3","author":"Ziehr","year":"2021","journal-title":"Crit. Care Explor."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s13054-020-03222-9","article-title":"Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia","volume":"24","author":"Tavazzi","year":"2020","journal-title":"Crit. Care"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcrc.2020.08.007","article-title":"Inhaled nitric oxide in mechanically ventilated patients with COVID-19","volume":"60","author":"Ferrari","year":"2020","journal-title":"J. Crit. Care"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/11795484211047065","article-title":"Inhaled nitric oxide via high-flow nasal cannula in patients with acute respiratory failure related to COVID-19","volume":"15","author":"Chandel","year":"2021","journal-title":"Clin. Med. Insights. Circ. Respir. Pulm. Med."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Ma, T., Zhang, Z., Chen, Y., Su, H., Deng, X., Liu, X., and Fan, Y. (2021). Delivery of nitric oxide in the cardiovascular system: Implications for clinical diagnosis and therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212166"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2018.04.025","article-title":"Use of gasotransmitters for the controlled release of polymer-based nitric oxide carriers in medical applications","volume":"279","author":"Yang","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/HYPERTENSIONAHA.114.04675","article-title":"Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: A randomized phase 2, double-blind, placebo-controlled study","volume":"65","author":"Kapil","year":"2015","journal-title":"Hypertension"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/ATVBAHA.118.312218","article-title":"Is homoarginine a protective cardiovascular risk factor?","volume":"39","author":"Karetnikova","year":"2019","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/bcp.13068","article-title":"Oral supplementation with L-homoarginine in young volunteers","volume":"82","author":"Atzler","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"750887","DOI":"10.3389\/fcvm.2021.750887","article-title":"Evaluation of endothelial dysfunction and inflammatory vasculopathy after SARS-CoV-2 infection\u2014a cross sectional study","volume":"8","author":"Jud","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","article-title":"Nitric oxide signalling in cardiovascular health and disease","volume":"15","author":"Farah","year":"2018","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/3\/240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:35:23Z","timestamp":1760135723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/3\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":181,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["metabo12030240"],"URL":"https:\/\/doi.org\/10.3390\/metabo12030240","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]}}}